Cancer Project

The idea of engineering a liposome with three monoclonal antibodies attached one liposome presents a daunting challenge.  Additionally, the binding affinity between each monoclonal antibody to its antigen must be considered carefully. It is important that the interaction between each antibody and antigen is relatively weak.  If one is too strong, the liposome will bind and inject its contents to healthy cells that merely express the antigen in normal levels, leading to cell death.